Xcelerate, Inc. Releases Message from CEO

MAULDIN, SC / ACCESSWIRE / January 3, 2023 / Xcelerate, Inc.‘s (OTCQB:”XCRT”) Mike O’Shea, CEO, these days released this letter and shareholder update.

I would like to first thank our shareholders for their ongoing assist through 2022 and would like all a healthy and affluent New Calendar year. 2022 was a extremely chaotic formulative 12 months for Xcelerate throughout which we obtained a number of milestones, which include

• Skilled a Regulation A supplying with the SEC and commenced raising further equity money to proceed the implementation of the Firm’s organization plan
• Obtained a controlling interest in AfiyaSasa Africa LLC, a get started-up health-related engineering and digital wellness organization that we consider is uniquely positioned to aid clients in acquiring nations satisfy their medical demands by extending the attain of doctors by means of the technological know-how.
• Obtained a portfolio of patents, patents pending and know-how licenses from HS Prescription drugs LLC, a producer and distributor of dermatological items for chronic wounds, burns and drug resistant infections.
• Appointed just one new Board member and three new Advisory Board associates.
• Attained patent pending status our to start with creation, “Surgical Resources with Focusing on Steering”. The system improves dealing with and precision of surgical applications by aiding the surgeon in observing the surgical web-site. It can adjust tool alignment and goal acquisition. It will combine goal marker projection in the device and use digital camera miniaturization. It will be in a position to give the surgeon a 1st-individual “tool see” of the surgical web page as properly as length details amongst resource and the meant issue of surgical incision in genuine time. This will enable treatments to both development quicker and with extreme precision.
• In conjunction with the patent filing, we have begun performing with OptiSensor GmbH to develop optics that can be built-in into our instrument, like a 1.7x.7 mm coloration digital camera. First trial of graphic excellent has confirmed incredibly profitable.
• Uplisted to the OTCQB industry from the pink sheets as a outcome of now getting a reporting enterprise with the SEC
• Had our designation as a “shell organization” taken out by OTC Markets.
• Expanded our patent portfolio defense in 9 supplemental international locations, like Korea.
• Started an initiative to discover possible companions to guide in the advancement of in excess of-the-counter health care products and solutions primarily based on our present IP.

As we enter 2023, I think that we are properly positioned to continue to execute our company prepare. Just one of our major objectives is to commence generating revenues from our jobs. To do so we have done or intend to do the pursuing:

• We will be forming a new wholly owned subsidiary, Xcelerate Manufacturers, to execute on our prepare to create a line of health care / pores and skin treatment items. In conjunction with this program, we will before long announce the appointment of more members to our Board of Advisors, who have many a long time of expertise in the over-the-counter product sector.
• Many thanks to the ongoing initiatives of Dr. Elegalla and his team in Tanzania, the computer software for the AfiyaSasa software has been translated to Swahili and the stop user apps are just about total. We anticipate being in a position to go are living with the software by Q2 of this yr.

As always, we are grateful for the aid of our shareholders. With each other we seem ahead to an fascinating and prosperous 2023.

Respectfully,

Mike O’Shea C.E.O.

ABOUT XCELERATE INC.

In May 2020, Xcelerate commenced implementation of a new enterprise strategy that encompasses two independent but connected businesses inside of the health-related business, including (i) owning and licensing the legal rights to various types of clinical tools and portfolio of patents, patents pending and technological innovation licenses and (ii) enhancement of digital well being technologies to assist sufferers in producing countries receive medical treatment by extending the achieve of medical professionals by way of the use of that know-how.

Supplemental facts about Xcelerate’s R&D plans can be considered at the newly up-to-date www.xcelerate.world beneath the heading of Technological innovation.

Harmless HARBOR

This press launch might have ahead-hunting details inside of the that means of Segment 21E of the Securities Trade Act of 1934, as amended (the “Trade Act”), like all statements that are not statements of historical actuality regarding the intent, belief or present-day expectations of the Organization, its directors or its officers with regard to, among the other things: (i) the Company’s funding designs (ii) developments influencing the Company’s fiscal issue or benefits of operations (iii) the Firm’s advancement approach and running approach and (iv) the declaration and payment of dividends. The words and phrases “could,” “would,” “will,” “hope,” “estimate,” “anticipate,” “think,” “intend,” and related expressions and variants thereof are supposed to identify ahead-seeking statements. Buyers are cautioned any this kind of ahead-looking statements are not ensures of upcoming performance and include threats and uncertainties, numerous of which are further than the Company’s capacity to control, and genuine results might vary materially from individuals projected in forward-on the lookout statements resulting from various factors.

Resource: Xcelerate, Inc.

See resource model on accesswire.com:
https://www.accesswire.com/733731/Xcelerate-Inc-Releases-Concept-from-CEO